Diana Elkis

Diana Elkis is an accomplished executive in the pharmaceutical industry, currently serving as Exec Director of Portfolio Strategy Implementation & Reporting in Global Drug Development at Bristol Myers Squibb since June 2020. With extensive experience leading strategic initiatives, Diana has previously held senior roles at AstraZeneca, including Sr Director of Portfolio Operations & Reporting and Director of R&D Strategic Planning. Diana's career began in business development and consulting roles, notably at PwC and MedImmune, focusing on life sciences and R&D strategy. Diana holds an MBA in Finance from Loyola University Maryland, a MSc in Cell Biology and Immunology from Tel Aviv University, and a B.Sc. in Microbiology from Tel Aviv University, along with foundational education from Krasnoyarsk State Medical University.